太极TAIJI品牌怎么样 申请店铺

我要投票 太极TAIJI在乌鸡白凤丸行业中的票数:123 更新时间:2025-02-05
太极TAIJI是哪个国家的品牌?「太极TAIJI」是重庆太极实业(集团)股份有限公司旗下著名品牌。该品牌发源于重庆,由创始人白礼西在1992期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
太极TAIJI怎么样

太极集团有限公司(简称太极集团)是中国企业500强之一,中国医药工业10强,资产200亿元,拥有“太极集团”(重庆太极实业(集团)股份有限公司)、“桐君阁”(重庆桐君阁股份有限公司)两家上市公司。“太极”(TAIJI)为中国首批驰名保护,OTC品牌药企第一名,2014年集团销售总额达230亿元,2021年将跨越千亿大关。

太极集团拥有10000家药房、13000名员工、20多家医药商业公司、13家制药厂及太极医药研究院、重庆中药研究院两大研发机构。1998年,太极集团与国内外15所院校合作建立博士后工作站;1999年,太极集团技术中心被认定为国家级企业技术中心;2013年,获国家批准建立太极院士专家工作站,中国工程院近20位院士成为太极研发顾问。

太极集团现有中西药品种1500多个、全国独家生产品种50多个、获得国家中药保护品种50多个、国家基药品种165个,获国家专利120项、年销售额逾亿元的品种15个。

太极集团的快速发展主要得益于日益增强的科研开发能力,日益完善的国内市场网络,日益成熟的信息化管理,先进的生产装备,畅销的外贸营销渠道,一流的员工队伍和管理团队,颇具中国特色的管理经验。更为重要的是,太极员工多年受“忠诚、责任、团结、努力”的太极精神熏陶,充满了“光大太极、振兴中华”的必胜信念。

习近平、张德江、江泽民、李鹏、温家宝、吴邦国、曾庆红、邹家华等党和国家领导人多次亲临太极集团视察工作,充分肯定太极集团的发展壮大之路,江泽民同志亲笔书写“太极集团”四个金光闪闪的大字予以鼓励。

阴阳互根方能相长,阴阳平衡万事万物方能和谐发展。太极集团渴望交流,期待合作,愿和您为中国医药事业走向世界而共同努力!

太极急支糖浆

批准文号:国药准字Z33020852

药品规格:每瓶装100毫升、200毫升

功能与主治:清热化痰、宣肺止咳。用于外感风热所致的咳嗽,症见发热、恶寒、胸膈满闷、咳嗽咽痛;急性支气管炎、慢性支气管炎急性发作见上述症候者。

用法与用量:口服。一次20~30ml,一日3~4次;儿童一岁以内一次5ml,一岁至三岁一次7ml,三岁至七岁一次10ml,七岁以上一次15ml,一日3~4次。

生产厂家:太极集团浙江东方制药有限公司

太极天胶

批准文号:国药准字Z62021196

药品规格:250克/盒

功能与主治:补血滋阴,润燥,止血。用于血虚萎黄,眩晕心悸,心烦不眠,肺燥咳嗽。

用法与用量:烊化兑服,3—9克

生产厂家:太极集团甘肃天水羲皇阿胶有限公司

Taiji Group Co., Ltd. (hereinafter referred to as Taiji Group) is one of the top 500 Chinese enterprises, one of the top 10 Chinese pharmaceutical industries, with assets of 20 billion yuan. It has two listed companies, Taiji Group (Chongqing Taiji industry (Group) Co., Ltd.) and TongJunGe (Chongqing TongJunGe Co., Ltd.). Taiji is one of the first batch of well-known protection companies in China, and the first OTC brand pharmaceutical enterprise. In 2014, the group's total sales reached 23 billion yuan, and in 2021, it will surpass 100 billion. Taiji Group has 10000 pharmacies, 13000 employees, more than 20 pharmaceutical commercial companies, 13 pharmaceutical factories, Taiji Pharmaceutical Research Institute and Chongqing Traditional Chinese Medicine Research Institute. In 1998, Taiji Group cooperated with 15 universities at home and abroad to establish a postdoctoral workstation; in 1999, Taiji Group Technology Center was recognized as a national enterprise technology center; in 2013, Taiji Group Technology Center was approved by the state to establish a Taiji academician expert workstation, and nearly 20 academicians of Chinese Academy of Engineering became Taiji R & D consultants. Taiji Group has more than 1500 varieties of Chinese and Western medicine, more than 50 national exclusive production varieties, more than 50 national protected varieties of traditional Chinese medicine, 165 national basic medicine varieties, 120 national patents, and 15 varieties with annual sales of more than 100 million yuan. The rapid development of Taiji Group is mainly due to the increasing research and development ability, the increasingly perfect domestic market network, the increasingly mature information management, advanced production equipment, the best-selling foreign trade marketing channels, the first-class staff and management team, and quite unique management experience in China. What's more, Taiji employees have been influenced by Taiji spirit of "loyalty, responsibility, unity and hard work" for many years, and are full of the belief of "Everbright Taiji and rejuvenation of China". Xi Jinping, Zhang Dejiang, Jiang Zemin, Li Peng, Wen Jiabao, Wu Bangguo, Zeng Qinghong, Zeng Qinghong and other party and state leaders visited Tai Chi Group for many times to inspect the work of Taiji group and fully affirmed the development and expansion of Taiji group. Comrade Hu personally wrote the four golden glittering characters of Taiji group to encourage them. Only when Yin and yang are mutually rooted can they grow, and when Yin and yang balance everything, can everything develop harmoniously. Taiji Group is eager to communicate and cooperate with you. We are willing to work with you for the development of Chinese medicine in the world! Approval No. of taijijijizhi syrup: gyzz z33020852 drug specification: 100ml and 200ml per bottle function and indications: clearing heat and resolving phlegm, promoting lung and relieving cough. It is used for cough caused by exogenous wind heat. Symptoms include fever, cold, chest and diaphragm fullness, cough and sore throat; acute bronchitis and chronic bronchitis with acute attack. Usage and dosage: oral. 20-30ml for one time, 3-4 times a day; 5ml for children under one year old, 7ml for children from one to three years old, 10ml for children from three to seven years old, 15ml for children over seven years old, 3-4 times a day. Manufacturer: Taiji Tianjiao of Zhejiang Oriental Pharmaceutical Co., Ltd. of Taiji group approval No.: gyzz z62021196 drug specification: 250G / box function and indications: nourishing blood and Yin, moistening dryness, hemostasis. It is used for deficiency of blood, yellowing, vertigo, palpitation, restlessness, lung dryness and cough. Usage and dosage: shunyua mixed service, 3-9g manufacturer: Taiji Group Gansu Tianshui Xihuang donkey hide gelatin Co., Ltd

本文链接: https://brand.waitui.com/0814962ca.html 联系电话:023-72800072

千城特选小程序码

7×24h 快讯

九洲药业:子公司浙江瑞博通过美国FDA现场检查

36氪获悉,九洲药业公告,公司子公司浙江瑞博制药有限公司于2024年10月28日至2024年11月1日期间接受了美国食品药品监督管理局的cGMP现场检查,检查范围涵盖质量体系、物料、生产、包装与标签、设备设施、实验室控制六大系统。近日,浙江瑞博收到美国FDA签发的现场检查报告(EIR,Establishment Inspection Report),该报告表明浙江瑞博已通过本次cGMP现场检查。检查范围为浙江瑞博涉及产品(非无菌原料药卡马西平、文拉法辛苯磺酸盐 —水合物以及药物中间体沙库巴曲)的生产制造。

2小时前

美图:公司旗下产品采用了DeepSeek技术

36氪获悉,据摩根士丹利透露,美图公司旗下的美图设计室已采用DeepSeek技术,主要为AI生成PPT相关功能。

2小时前

硅业分会:多晶硅企业年后集中签单在即,硅料环节持续去库

36氪获悉,据中国有色金属工业协会硅业分会消息,本周逢春节假期,多晶硅企业整体暂无规模性签单,多晶硅市场价格维持稳定。n型复投料成交价格区间为3.90-4.50万元/吨,成交均价为4.17万元/吨,n型颗粒硅成交价格区间为3.80-4.10万元/吨,成交均价为3.90万元/吨,p型多晶硅成交价区间为3.20-3.60万元/吨,成交均价为3.40万元/吨。本周多晶硅企业正常执行前期订单,年后订单仍在洽谈中。目前下游硅片企业排产有上调预期,对多晶硅需求量稳步增长。

2小时前

传宁德时代考虑提交香港上市申请,官方暂无回应

今日有消息称,宁德时代据称考虑在未来几周提交香港上市申请。针对此事,宁德时代方面暂无回应。此前,2024年底也有外媒报道称,宁德时代考虑最快于2025年在香港上市,筹集至少50亿美元。(新浪科技)

2小时前

华泰股份:股票连续12个月收盘价均低于每股净资产,公司制定估值提升计划

36氪获悉,华泰股份公告,公司股票连续12个月每个交易日收盘价均低于最近一个会计年度经审计的每股归属于公司普通股股东的净资产,根据《上市公司监管指引第10号——市值管理》的相关规定,华泰股份制定估值提升计划。公司估值提升计划已经公司第十一届董事会第四次会议审议通过。华泰股份估值提升计划将围绕生产经营、现金分红、股份回购、股东增持、投资者关系管理以及信息披露等方面。

2小时前

本页详细列出关于中联的品牌信息,含品牌所属公司介绍,中联所处行业的品牌地位及优势。
咨询